Altera shares jump on talk of Intel bid

Shares of computer chipmaker Altera are up Friday amid renewed speculation about an acquisition by industry giant Intel. Shares of San Jose, Ca.-based Altera were 4.34%% or $2.04 higher, at

Read More

Yellen says Fed on track for first rate hike this year

Federal Reserve Chair Janet Yellen said Friday the central bank remains on track to raise interest rates this year but will do so gradually, adding that she expects the economy

Read More

Google unveils Fi, new wireless service

Google has unveiled its hotly anticipated wireless service Project Fi to prod the telecom industry to make mobile service in the U.S. faster, easier and less expensive. The Internet giant

Read More

Relief rally: Stocks soar on Fed rate news

U.S. stocks rallied sharply after the Federal Reserve ruled out interest rate hikes at next month’s meeting and said it had not “decided on the timing” of the first rate

Read More

New Data on Two Anavex Alzheimer’s Drugs to be Unveiled at AD/PD 2015

NEW YORK, March 19, 2015 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s and other central nervous system

Read More

Anavex to Participate in Phase 3 Clinical Trials Panel at AD/PD 2015

NEW YORK, March 17, 2015 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s and other central nervous system

Read More

Athgo Will Host Sixth Global Innovation Forum “Athgothon” at the World Bank in Washington D.C. from August 12-14, 2015

Los Angeles, C.A. – March 16, 2015 – Since its founding in 2002, Athgo International (http://bit.ly/1x6c0n3) has been a major international force for change. Athgo offers a unique array of

Read More

Anavex Appoints Epilepsy and Clinical Trial Methodology Expert to Scientific Advisory Board

NEW YORK, March 12, 2015 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system

Read More

Anavex to Present at Sigma-1 Receptors Symposium

NEW YORK, March 10, 2015 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL) a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system (CNS)

Read More

Corporate Review and Seven Star Enterprises Explore Gold and Silver Investments

March 5, 2015 – Boca Raton, Florida — Many regard gold and silver as strong investment options to protect against inflation. Seven Star Enterprises International works to advise investors about

Read More

Paradigm Life Teaches Individuals How to Own Their Financial Future on Award Winning Show

Boca Raton, FL – March 5, 2015 — Education makes for an easier life, and nobody understands that better than Patrick Donohoe, President and CEO of Paradigm Life. Donohoe speaks to

Read More

Anavex Appoints Scientific Advisory Board Member With Expertise in Protein Misfolding Neurodegenerative Diseases

NEW YORK, March 5, 2015 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL), a clinical-stage biopharmaceutical company developing drug candidates to treat Alzheimer’s disease, other central nervous system

Read More